These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 32338172

  • 1. The Impact of Intrathecal Baclofen Therapy on Health-related Quality of Life for Children with Marked Hypertonia.
    Stewart K, Copeland L, Lewis J.
    Dev Neurorehabil; 2020 Nov; 23(8):542-547. PubMed ID: 32338172
    [Abstract] [Full Text] [Related]

  • 2. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
    Baker KW, Tann B, Mutlu A, Gaebler-Spira D.
    J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.
    Krach LE, Kriel RL, Day SM, Strauss DJ.
    Dev Med Child Neurol; 2010 Jul; 52(7):672-6. PubMed ID: 19811519
    [Abstract] [Full Text] [Related]

  • 5. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.
    Kraus T, Gegenleitner K, Svehlik M, Novak M, Steinwender G, Singer G.
    Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420
    [Abstract] [Full Text] [Related]

  • 6. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy.
    McCoy AA, Fox MA, Schaubel DE, Ayyangar RN.
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127
    [Abstract] [Full Text] [Related]

  • 7. Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey.
    Lodh R, Amin S, Ammar A, Bellis L, Brink P, Calisto A, Crimmins D, Eunson P, Forsyth RJ, Goodden J, Kaminska M, Kehoe J, Kirkpatrick M, Kumar R, Leonard J, Lording A, Martin K, Miller R, Mordekar SR, Pettorini B, Smith M, Smith R, Sneade C, Whitney A, Vloeberghs M, Zaki H, Lumsden DE.
    Arch Dis Child; 2021 Dec; 106(12):1202-1206. PubMed ID: 33853760
    [Abstract] [Full Text] [Related]

  • 8. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN.
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
    Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS, Dutch Study Group on Child Spasticity.
    Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications.
    Murphy NA, Irwin MC, Hoff C.
    Arch Phys Med Rehabil; 2002 Dec; 83(12):1721-5. PubMed ID: 12474176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life.
    Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP.
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1509-15. PubMed ID: 17084128
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity.
    Eek MN, Olsson K, Lindh K, Askljung B, Påhlman M, Corneliusson O, Himmelmann K.
    Dev Med Child Neurol; 2018 Jan; 60(1):94-99. PubMed ID: 29148568
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.